Prospective Snapshot Audit of Distal Pancreatectomy in Spain
Spadispan
SPAnish DIStal PANcreatectomy Snapshot Study
1 other identifier
observational
500
0 countries
N/A
Brief Summary
Distal pancreatectomy is the surgical technique performed to treat many pancreatic diseases located in neck and tail of the pancreas. Laparoscopic approach is the gold standard but in many centres the percentage of laparoscopic approach is still low. This technique has low mortality but 30% morbidity mostly related to pancreatic fistula. Some new devices (linear stapler, energy devices and patches) seem to decrease pancreatic fistula but there is not evidence based medicine that confirm the results published usually in unicentric studies.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Jul 2021
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
May 17, 2021
CompletedFirst Posted
Study publicly available on registry
May 25, 2021
CompletedStudy Start
First participant enrolled
July 1, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 31, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
October 31, 2022
CompletedMay 25, 2021
May 1, 2021
1.1 years
May 17, 2021
May 19, 2021
Conditions
Outcome Measures
Primary Outcomes (2)
Morbidity at 90 days
Morbidity measured with CCI and Clavien at 90 days
90 days
Laparoscopic approach
Laparoscopic or laparotomy approach
1 year
Secondary Outcomes (1)
Pancreatic fistula
90 days
Study Arms (1)
Distal pancreatectomy
All cases operated on performing distal pancreatectomy in involved Units
Interventions
We are going to collect all cases
Eligibility Criteria
All scheduled distal pancreatectomies performed in on year in each Unit.
You may qualify if:
- All distal pancreatectomies performed in involved Units
You may not qualify if:
- No sign of informed consent for entering in the study
- Emergency procedures
Contact the study team to confirm eligibility.
Sponsors & Collaborators
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- MD PHD Senior consultant HPB surgeon
Study Record Dates
First Submitted
May 17, 2021
First Posted
May 25, 2021
Study Start
July 1, 2021
Primary Completion
July 31, 2022
Study Completion
October 31, 2022
Last Updated
May 25, 2021
Record last verified: 2021-05
Data Sharing
- IPD Sharing
- Will not share
CRD is done. It should be sent to local investigators and fulfilled in a Castor formulary.